GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumito AB (NGM:LUMITO) » Definitions » EV-to-EBIT

Lumito AB (NGM:LUMITO) EV-to-EBIT : -8.44 (As of Jun. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Lumito AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lumito AB's Enterprise Value is kr209.28 Mil. Lumito AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-24.79 Mil. Therefore, Lumito AB's EV-to-EBIT for today is -8.44.

The historical rank and industry rank for Lumito AB's EV-to-EBIT or its related term are showing as below:

NGM:LUMITO' s EV-to-EBIT Range Over the Past 10 Years
Min: -74.47   Med: 0   Max: 0
Current: -8.44

NGM:LUMITO's EV-to-EBIT is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 20.415 vs NGM:LUMITO: -8.44

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Lumito AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr502.31 Mil. Lumito AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-24.79 Mil. Lumito AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -4.94%.


Lumito AB EV-to-EBIT Historical Data

The historical data trend for Lumito AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumito AB EV-to-EBIT Chart

Lumito AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial -50.57 -23.43 - - -

Lumito AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -20.26

Competitive Comparison of Lumito AB's EV-to-EBIT

For the Diagnostics & Research subindustry, Lumito AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumito AB's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumito AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lumito AB's EV-to-EBIT falls into.



Lumito AB EV-to-EBIT Calculation

Lumito AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=209.281/-24.792
=-8.44

Lumito AB's current Enterprise Value is kr209.28 Mil.
Lumito AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-24.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumito AB  (NGM:LUMITO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lumito AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-24.792/502.30565
=-4.94 %

Lumito AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr502.31 Mil.
Lumito AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-24.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumito AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Lumito AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumito AB (NGM:LUMITO) Business Description

Traded in Other Exchanges
N/A
Address
Magistratsvagen 10, Lund, SWE, SE-226 43
Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed a development and business plan for the development of an instrument for digital pathology that improves the quality of tissue sample mapping.

Lumito AB (NGM:LUMITO) Headlines

No Headlines